STOCKHOLDERS EQUITY (Tables)

6 Months Ended

Jun. 30, 2024

STOCKHOLDERS' EQUITY

Schedule of share based compensation expenses

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Share-based compensation expense:
Stock options	$	47,558	$	-	$	63,469	$	-
RSUs		47,364		-		237,378		-
Total share-based compensation expense	$	94,922	$	-	$	300,847	$	-

Schedule of annual weighted average assumptions

	Six Months Ended
Grant-Date Weighted-Average Assumptions	June 30, 2024
Expected term (in years)		3.9
Risk-free interest rate		4.3	%
Expected dividend yield		0.0	%
Expected volatility		140.4	%
Fair value per share of options granted	$	0.17

Schedule of stock option activity

					Weighted-Average
			Weighted-		Remaining		Aggregate
			Average		Contractual		Intrinsic
	Shares		Exercise Price		Term (in years)		Value
Options outstanding, December 31, 2023		-		n/a		n/a		n/a
Granted		3,900,000	$	0.22		n/a		n/a
Exercised		-		n/a		n/a		n/a
Forfeited		-		n/a		n/a		n/a
Expired		-		n/a		n/a		n/a
Options outstanding, June 30, 2024		3,900,000	$	0.22		3.6	$	450,000
Nonvested options, June 30, 2024		3,900,000	$	0.22		3.6	$	450,000
Vested and exercisable options, June 30, 2024		-		n/a		n/a		n/a

Schedule of Resricted stock unit activity

				Weighted-Average
				Grant-Date
	Shares			Fair Value
Nonvested shares at December 31, 2023		-			n/a
Granted		2,670,000		$	0.22
Vested		(791,667	)	$	0.22
Forfeited		-			n/a
Nonvested shares at June 30, 2024		1,878,333		$	0.23

Schedule of Warrants outstanding

Number of warrants		Exercise Price		Expiration Date	Remaining life (years)
	2,285,715	$	0.46	7/31/2025		1.08
	804,000	$	0.46	1/27/2026		1.58
	7,650,000	$	0.85	8/3/2026		2.09
	1,606,500	$	0.85	2/1/2026		1.59
	12,346,215